Furthermore, Haidalimumab could effectively neutralize rhTNFα toxicity in a C57BL/6 mouse model, and displayed significant therapeutic effect in a TNF-Tg mouse arthritis model. The gene discussed is TNF; the disease is arthritic joint disease.